Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics's email is info@brainstorm-cell.com
and
Brainstorm Cell Therapeutics's phone number is 646-666-3188
.
BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD). NurOwn™, our proprietary, first-of-its-kind technology for the propagation and differentiation of autologous Mesenchymal Stem Cells (MSCs) into NeuroTrophic Factor (NTF)-secreting cells and their transplantation at or near the site of damage, offers the hope of conquering neurodeg...
read more
BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD). NurOwn™, our proprietary, first-of-its-kind technology for the propagation and differentiation of autologous Mesenchymal Stem Cells (MSCs) into NeuroTrophic Factor (NTF)-secreting cells and their transplantation at or near the site of damage, offers the hope of conquering neurodegenerative diseases. We are currently conducting a Phase IIa ALS clinical trial with NurOwn at the Hadassah University Medical Center in Jerusalem. In this safety and preliminary efficacy trial, 12 patients will receive combined intramuscular and intrathecal administration of neuron cells in three cohorts with increasing doses. The study participants will be followed for three to six months after transplantation. The company also plans to begin a Phase II clinical trial in the USA in 2013, pending FDA approval. On February 2011, NurOwn was granted Orphan Drug designation by the FDA. Over 20 publications in leading scientific journals demonstrating neuron mechanism of action, pharmacology and in vivo efficacy have been published by the scientific team.
show less
Website | brainstorm-cell.com | |
Industry | Biotechnology | |
Location | Israel | |
Employees | 30 | |
Founded | 2004 |
HQ | 605 Third Avenue 34th Floor | |
Phone | 646-666-3188 | |
info@brainstorm-cell.com | ||
Funding | 51,628,019 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | brainstorm-cell.com | |
Industry | Biotechnology | |
Location | Israel | |
Employees | 30 | |
Founded | 2004 | |
linkedin.com/company/brainstorm-cell-therapeutics | ||
HQ | 605 Third Avenue 34th Floor | |
Phone | 646-666-3188 | |
info@brainstorm-cell.com | ||
Funding | 51,628,019 USD |
Email Patterns for Brainstorm Cell Therapeutics
Top Competitors for Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics Questions
Where are Brainstorm Cell Therapeutics's headquarters?
Brainstorm Cell Therapeutics's headquarters are in 605 Third Avenue 34th Floor
What is Brainstorm Cell Therapeutics's phone number?
Brainstorm Cell Therapeutics's phone number is 646-666-3188
What is Brainstorm Cell Therapeutics's official website?
Brainstorm Cell Therapeutics's website is brainstorm-cell.com
How many employees are working in Brainstorm Cell Therapeutics right now?
Brainstorm Cell Therapeutics has
30 employees.
View the Email and Phone Numbers for all 30 working at Brainstorm Cell Therapeutics.
What is Brainstorm Cell Therapeutics's industry?
Brainstorm Cell Therapeutics's industry is
Biotechnology
Who are Brainstorm Cell Therapeutics's top competitors?
Brainstorm Cell Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Brainstorm Cell Therapeutics's email address?
Brainstorm Cell Therapeutics's email address is info@brainstorm-cell.com
What are Brainstorm Cell Therapeutics's categories?
Brainstorm Cell Therapeutics's categories are Biotechnology, Health Care, Medical, Therapeutics
What is Brainstorm Cell Therapeutics's location?
Brainstorm Cell Therapeutics's location is
Israel
When was Brainstorm Cell Therapeutics's founded?
Brainstorm Cell Therapeutics's founding year is 2004
What is Brainstorm Cell Therapeutics's funding?
Brainstorm Cell Therapeutics's funding is 51,628,019 USD
What is Brainstorm Cell Therapeutics's current status?
Brainstorm Cell Therapeutics's current status is ipo
Top Brainstorm Cell Therapeutics Employees
Executive Director And Executive Vice President, Chief Business Officer
uyablonka@brainstorm-cell.com
+1201-488-0460
Chief Executive Officer
info@acc-holdings.com
+1646-666-3188
Senior Vice President, Head Market Access And Pricing
bwhite72@q.com
+1480-767-2624
President And Chief Medical Officer
rkern@mtsinai.on.ca
+1617-914-5931
Executive Vice President And Head Of Global Clinical Research
bayespower@gmail.com
+1617-914-5931
Chief Financial Officer
lsossover@brainstorm-cell.com
+1646-666-3188
Executive Director And Executive Vice President, Chief Business Officer
uyablonka@brainstorm-cell.com
+1201-488-0460